Award recordCONTRACT

HELSINN THERAPEUTICS (U.S.), INC.

PIID 36E79724A0004· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2024· $0 net obligations· UEI H7RDUVXHP8L3· NJ

Description

THIS MODIFICATION IS ISSUED TO CANCEL BPA 36E79724A0004.

Base award description: BPA FOR VALCHLOR

First action · last action
2023-11-13 · 2025-02-27
Transactions
5
First transaction's obligation
$0
Base + all options value (sum of deltas)
$15,475,952
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D70240
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 5 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2023-11-13 · this action $0 · running total $0Modification P00001 · 2023-12-06 · this action $0 · running total $0Modification P00002 · 2024-09-20 · this action $0 · running total $0Modification P00003 · 2024-12-16 · this action $0 · running total $0Modification P00004 · 2025-02-27 · this action $0 · running total $0
  • Base2023-11-13+$0= $0
  • Mod P000012023-12-06+$0= $0
  • Mod P000022024-09-20+$0= $0
  • Mod P000032024-12-16+$0= $0
  • Mod P000042025-02-27+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2023-11-13+$0$0BPA FOR VALCHLOR
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-12-06+$0$02024 PUBLIC LAW PRICING UPDATES
Mod P00002· EXERCISE AN OPTION2024-09-20+$0$0THIS MODIFICATION IS ISSUED TO EXERCISE OPTION YEAR 1 ON BPA 36E79724A0004.
Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-12-16+$0$02025 PUBLIC LAW PRICING UPDATES
Mod P00004· LEGAL CONTRACT CANCELLATION2025-02-27+$0$0THIS MODIFICATION IS ISSUED TO CANCEL BPA 36E79724A0004.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI H7RDUVXHP8L3)

AwardOffice · PSC / listingNet obligationsFY
36C24525N0877245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$14,560FY2025
36E79725A0008NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36F79725D0061NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36C24620F0088246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6850 · MISCELLANEOUS CHEMICAL SPECIALTIES$36,471FY2020
36C24620N0274246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS$36,471FY2020
36C24619N0678246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS$36,471FY2019

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79724A0004_3600 · retrieved 2026-09-26.